2 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
Follow SNV1521: new trials by email Literature Review of SNV1521 trials Research Report on SNV1521
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| First in Human Study of SNV1521 With a RAS Inhibitor for People With Advanced Pancreatic Cancer SNV1521, daraxonrasib - Pancreatic Cancer, Pancreatic Acinar Carcinoma | Phase 1 | Recruiting | ParVation Therapeutics, Inc. | 40 | 2026-09-01 | 2026-10-27 |
| SNV1521 in Participants With Advanced Solid Tumors SNV1521, DB-1310, Abiraterone - Advanced Solid Tumor | Phase 1 | Recruiting | ParVation Therapeutics, Inc. | 400 | 2024-02-23 | 2026-06-25 |
ParVation Therapeutics, Inc. (2)
United States (2) · Australia (1) · Belgium (1) · Canada (1) · France (1) · Italy (1) · Spain (1)